c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]

• Main Authors: Lin SH, Wang HK, Yeh KT, Tai HC, Wang HY, Huang LR, Chiu CW, Chung CM, Velmurugan BK
• Format: Article
• Language: English
• Published: Dove Medical Press 2019-08-01
• Series: Cancer Management and Research
• Online Access: https://www.dovepress.com/httpssitesgooglecomsitecorrigendum-dmpiheguiderevisedaugus-peer-reviewed-article-CMAR

Lin SH, Wang HK, Yeh KT, et al. Cancer Manag Res. 2019;11:5163–5169.Following a review of the paper post-publication, the authors found two errors.The authors advised that firstly, they incorrectly listed the CCH IRB number on page 5164. Therefore, the sentence “This study was approved by the Ethics Committees of Changhua Christian Hospital (Changhua, Taiwan), and we adhered to the guidelines approved by CCH IRB (no. 170143).” should instead read “This study was approved by the Ethics Committees of Changhua Christian Hospital (Changhua, Taiwan), and we adhered to the guidelines approved by CCH IRB (no. 170413).”The authors advised that secondly, they incorrectly listed the wrong protein name in Table 3 on page 5167. This was the result of a typing error when they reviewed the manuscript. The title “The effect of clinicopathologic factor and UNC13C expression on mortality density and adjusted hazard ratio (aHR) among OSCC patients” should instead read “The effect of clinicopathologic factor and c-MYC expression on mortality density and adjusted hazard ratio (aHR) among OSCC patients.”Read the original article